Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer
Public ClinicalTrials.gov record NCT01326312. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II, Open Label, Dose Finding Study of the Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer Compared to a Luteinizing Hormone Releasing Hormone Agonist
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether GTx 758 is effective in achieving and maintaining castrate testosterone levels in men with advanced prostate cancer.
Study identification
- NCT ID
- NCT01326312
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 159 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years to 80 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2011 (Type not available)
- Primary completion
- Dec 2012 (Actual)
- Completion
- Dec 2012 (Actual)
- Last update posted
- Jun 22, 2023
2011 – 2012
United States locations
- U.S. sites
- 36
- U.S. states
- 17
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GTx Investigative Site | Phoenix | Arizona | 85032 | — |
| GTx Investigative Site | La Mesa | California | 91942 | — |
| GTx Investigative Site | Los Angeles | California | 90048 | — |
| GTx Investigative Site | San Bernardino | California | 92404 | — |
| GTx Investigative Site | Middlebury | Connecticut | 06762 | — |
| GTx Investigative Site | Aventura | Florida | 33180 | — |
| GTx Investigative Site | Daytona Beach | Florida | 32114 | — |
| GTx Investigative Site | Wellington | Florida | 33449 | — |
| GTx Investigative Site | Marietta | Georgia | 30060 | — |
| GTx Investigative Site | Springfield | Illinois | 62703 | — |
| GTx Investigative Site | Fort Wayne | Indiana | 46825 | — |
| GTx Investigative Site | Indianapolis | Indiana | 46260 | — |
| GTx Investigative Site | Jeffersonville | Indiana | 47130 | — |
| GTx Investigative Site | Annapolis | Maryland | 21401 | — |
| GTx Investigative Site | Baltimore | Maryland | 21204 | — |
| GTx Investigative Site | Brick | New Jersey | 08724 | — |
| GTx Investigative Site | Lawrenceville | New Jersey | 08648 | — |
| GTx Investigative Site | Albuquerque | New Mexico | 87109 | — |
| GTx Investigative Site | Albany | New York | 12208 | — |
| GTx Investigative Site | Garden City | New York | 11530 | — |
| GTx Investigative Site | New York | New York | 10016 | — |
| GTx Investigative Site | Oneida | New York | 13421 | — |
| GTx Investigative Site | Syracuse | New York | 13210 | — |
| GTx Investigative Site | Chapel Hill | North Carolina | 27514 | — |
| GTx Investigative Site | Raleigh | North Carolina | 27607 | — |
| GTx Investigative Site | Cincinnati | Ohio | 45212 | — |
| GTx Investigative Site | Columbus | Ohio | 43220 | — |
| GTx Investigative Site | Bala-Cynwyd | Pennsylvania | 19004 | — |
| GTx Investigative Site | Lancaster | Pennsylvania | 17606 | — |
| GTx Investigative Site | Pittsburgh | Pennsylvania | 15232 | — |
| GTx Investigative Site | Myrtle Beach | South Carolina | 29572 | — |
| GTx Investigative Site | Memphis | Tennessee | 38117 | — |
| GTx Investigative Site | Nashville | Tennessee | 37209 | — |
| GTx Investigative Site | Arlington | Texas | 76017 | — |
| GTx Investigative Site | Houston | Texas | 77030 | — |
| GTx Investigative Site | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01326312, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 22, 2023 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01326312 live on ClinicalTrials.gov.